Vancomycin resistant enterococcus risk factors for hospital colonization in hematological patients: a matched case-control studyMarianna Meschiari, Cristina Mussini, Fabio Forghieri et al.|Antimicrobial Resistance and Infection Control|2023Cited by 24
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort StudyCristina Mussini, Giovanni Guaraldi, Alessandro Cozzi‐Lepri et al.|Viruses|2023Cited by 5
Impact of vancomycin resistance on attributable mortality among <i>Enterococcus faecium</i> bloodstream infections: propensity score analysis of a large, multicentre retrospective studyMarco Del Monte, Marianna Meschiari, Shaniko Kaleci et al.|Journal of Antimicrobial Chemotherapy|2025Cited by 5
Severe acute respiratory syndrome coronavirus 2 infection in patients with hematological malignancies in the Omicron era: Respiratory failure, need for mechanical ventilation and mortality in seronegative and seropositive patientsErica Franceschini, Cristina Mussini, Valentina Menozzi et al.|eJHaem|2024Cited by 3
P25. Characteristics, treatment options, and predictors of clinical failure among Pseudomonas aeruginosa infection with microbiologically confirmed intermediate or resistant carbapenem susceptibility profile: a multicenter clinical experience on behalf of CASPER (CArbapenem-reSistant <i>Pseudomonas aERuginosa</i> during and after the COVID-19 pandemic) study groupAndrea Dessilani, Marianna Meschiari, Shaniko Kaleci et al.|JAC-Antimicrobial Resistance|2025Cited by 0